Description
Vesugen (KED)
Vesugen, also known as KED (Lys-Glu-Asp), is a synthetic tripeptide bioregulator developed as part of the research pioneered by Professor Vladimir Khavinson. It is designed to target vascular endothelial cells and support the health of the vascular system. Vesugen is studied for its potential vasoprotective, geroprotective (anti-aging), and neuroprotective properties through epigenetic regulation of gene expression, particularly genes involved in cell proliferation (such as Ki-67).
Key Benefits
- Vascular Health Support: Helps protect and regenerate vascular endothelium, potentially improving blood flow and reducing age-related vascular decline.
- Anti-Aging / Geroprotective Effects: May slow biological aging by supporting cellular regeneration, improving organ function, and enhancing anabolic processes.
- Cardiovascular & Circulatory Benefits: Studied for improvements in blood flow, endothelial function, and metabolic regulation.
- Neuroprotective Potential: May support cognitive function, neuron survival, and synaptic plasticity.
- Additional Research Areas: Investigated for benefits in erectile function, exercise tolerance, inflammation modulation, and overall tissue health in aging populations.
Administration Options
- Oral / Sublingual (Lingual): Common in bioregulator formulations (capsules or drops under the tongue).
- Subcutaneous (SQ) Injection: Used in research settings for systemic delivery.
- Typical Cycles: Often used in short courses (10–30 days) followed by breaks of several months, rather than continuous daily use.
Note: Vesugen is not FDA-approved and is used exclusively for research purposes.
Potential Side Effects
- Generally Well-Tolerated: Considered to have a favorable safety profile in available studies.
- Mild: Occasional headache, nausea, stomach discomfort, or injection site reactions (if injected).
- Rare: Mild allergic reactions or gastrointestinal upset.
Peptide Combinations
Peptides it pairs well with:
- Pinealon (for enhanced neuroprotective and CNS support)
- BPC-157 or TB-500 (for complementary tissue repair and regenerative effects)
- Other Khavinson bioregulators (e.g., Epitalon, Cardiogen) for broader anti-aging protocols
Peptides/Drugs to Avoid Combining:
- Limited interaction data available; caution is advised with strong blood pressure medications or compounds that significantly alter vascular dynamics without medical supervision.


Reviews
There are no reviews yet.